Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
TORRENT PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,723319-   
Low Rs1,243230-   
Sales per share (Unadj.) Rs284.294.9-  
Earnings per share (Unadj.) Rs36.8-23.9-  
Cash flow per share (Unadj.) Rs57.7-19.8-  
Dividends per share (Unadj.) Rs22.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs183.174.5-  
Shares outstanding (eoy) m338.45168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.22.9 180.3%   
Avg P/E ratio x40.3-11.5 -350.9%  
P/CF ratio (eoy) x25.7-13.9 -185.5%  
Price / Book Value ratio x8.13.7 219.6%  
Dividend payout %59.80-   
Avg Mkt Cap Rs m501,77946,340 1,082.8%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m16,7772,908 576.8%   
Avg. sales/employee Rs Th03,730.7-  
Avg. wages/employee Rs Th0677.5-  
Avg. net profit/employee Rs Th0-940.1-  
INCOME DATA
Net Sales Rs m96,20216,016 600.7%  
Other income Rs m632112 563.7%   
Total revenues Rs m96,83416,128 600.4%   
Gross profit Rs m28,240-2,775 -1,017.5%  
Depreciation Rs m7,066691 1,022.2%   
Interest Rs m3,334434 768.6%   
Profit before tax Rs m18,472-3,788 -487.6%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,019237 2,542.8%   
Profit after tax Rs m12,452-4,036 -308.6%  
Gross profit margin %29.4-17.3 -169.4%  
Effective tax rate %32.6-6.2 -521.5%   
Net profit margin %12.9-25.2 -51.4%  
BALANCE SHEET DATA
Current assets Rs m53,13711,730 453.0%   
Current liabilities Rs m54,4736,600 825.3%   
Net working cap to sales %-1.432.0 -4.3%  
Current ratio x1.01.8 54.9%  
Inventory Days Days15111 14.0%  
Debtors Days Days7124 6.0%  
Net fixed assets Rs m91,3906,838 1,336.6%   
Share capital Rs m1,69274 2,275.8%   
"Free" reserves Rs m60,2880-   
Net worth Rs m61,98112,571 493.1%   
Long term debt Rs m24,9624,418 565.1%   
Total assets Rs m144,68223,747 609.3%  
Interest coverage x6.5-7.7 -84.6%   
Debt to equity ratio x0.40.4 114.6%  
Sales to assets ratio x0.70.7 98.6%   
Return on assets %10.9-15.2 -71.9%  
Return on equity %20.1-32.1 -62.6%  
Return on capital %25.1-19.8 -126.6%  
Exports to sales %21.80-   
Imports to sales %00-   
Net fx Rs m17,2590-   
CASH FLOW
From Operations Rs m23,6811,367 1,732.3%  
From Investments Rs m-24,153-420 5,754.0%  
From Financial Activity Rs m7744,009 19.3%  
Net Cashflow Rs m1,1014,957 22.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.4 Rs / ZAR

Compare TORRENT PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: IPCA LABS  GUFIC BIOSCIENCE  ALPA LAB  FREDUN PHARMA  LUPIN  



Today's Market

Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red(10:30 am)

Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.